Pharmaceutical Products

Manufacturing complex pharmaceutical products with new technologies

March 11, 2024 - Scientific advancement and increasingly complex pharmaceutical products have reshaped the healthcare industry, providing novel tools and solutions for managing broad conditions, from acute viral infections to chronic diseases to oncology. As science evolves, developing increasingly complex pharmaceutical products, manufacturers and biopharmaceutical companies must evolve their...

Read More


More Articles

FDA Investigates the Safety of GLP-1 Weight Loss Drugs

by Veronica Salib

Yesterday, on January 11, 2024, the United States FDA issued a drug safety communication updating the public on an ongoing investigation of glucagon-like peptide-1 receptor agonists. The administration...

AllianceRx Walgreens Selected to Distribute XDEMVY

by Alivia Kaylor

AllianceRx Walgreens Pharmacy, a leading specialty and home delivery pharmacy in the United States and a subsidiary of Walgreens, has been selected as one of four specialty pharmacies to distribute...

Ensuring Drug Safety Through Regulatory Compliance

by Alivia Kaylor

In healthcare technology, the intersection of science and regulations is where innovation meets responsibility. Nowhere is this more evident than in the pharmaceutical industry, where drug safety is paramount. Regulatory compliance plays a...

Drug Shortages: A Growing Concern for the Healthcare Industry Worldwide

by Alivia Kaylor

Drug shortages have become a growing concern for the healthcare industry worldwide as patients are left without essential medications, and healthcare providers struggle to find alternative treatments. The problem has been rising for...

FDA Domestic and Foreign Oversight Protocols and Violation Responses

by Veronica Salib

The United States Food and Drug Administration (FDA) has been criticized repeatedly for shortcomings and flaws in its oversight protocols. Understanding the current regulations that the FDA follows for assessing drug manufacturing...

Analyzing Returns on Investment from Pharmaceutical Innovation

by Veronica Salib

In an annual report focused on the return on investment (ROI) from pharmaceutical innovation, Deloitte analyzed research and development (R&D) in the pharmaceutical industry and the resulting outcomes throughout 2022. Considering the...

Astellas and Seagen Announce Results on a Drug for Urothelial Cancer

by Veronica Salib

According to a recent press release, Astellas and Seagen have teamed up to develop a combined treatment for urothelial cancer in patients who are ineligible to receive cisplatin chemotherapy. The new...

Recent Articles